(Q46563654)

English

Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study

scientific article published on 20 April 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

nephrotic syndrome

1 reference

based on heuristic

inferred from title

idiopathic nephrotic syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hussein Sheashaa

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

Ihab Mahmoud

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

Fathy El-Basuony

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

Amr El-Husseini

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

Nabil Hassan

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

Mahmoud El-Baz

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

Nagy Sayed Ahmed

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

Mohamed Sobh

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

publication date

20 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

International Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

39

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

923-928

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

Cyclosporine A for treatment of nephrotic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of the nephrotic syndrome associated with primary glomerulonephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine in the treatment of idiopathic nephrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of focal segmental glomerulosclerosis: evidence-based recommendations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and side effects of cyclosporin A in nephrotic syndrome of childhood.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary focal segmental glomerulosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine therapy for psoriasis: serum creatinine measurements are an unreliable predictor of decreased renal function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-center experience with cyclosporine in refractory nephrotic syndrome in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine A induced remission of relapsing nephrotic syndrome in children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17447154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11255-007-9194-X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/17447154

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46563654&oldid=2118474827"